​

Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?


OverviewForecastFinancialsChart

Oruka Therapeutics Ownership Summary


Oruka Therapeutics is owned by 122.04% institutional investors, 1.23% insiders. Fmr is the largest institutional shareholder, holding 16.14% of ORKA shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.87% of its assets in Oruka Therapeutics shares.

ORKA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOruka Therapeutics122.04%1.23%-23.27%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr10.15M16.14%$845.30M
Blackrock funding, inc. /de5.21M8.29%$433.96M
Vr adviser4.15M7.52%$394.81M
Fairmount funds management3.71M6.72%$352.63M
Rtw investments, lp3.14M5.69%$298.74M
Vanguard group2.45M5.57%$74.37M
Capital world investors3.43M5.45%$285.61M
State street2.82M4.48%$234.62M
Vanguard capital management2.64M4.21%$220.24M
Paradigm biocapital advisors lp2.14M3.89%$204.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Remedium capital partners954.15K29.05%$79.47M
Fairmount funds management3.71M23.31%$352.63M
Vr adviser4.15M11.97%$394.81M
Avidity partners management lp760.42K11.59%$72.37M
Paradigm biocapital advisors lp2.14M3.82%$204.09M
B group75.00K3.35%$7.14M
Bellevue group1.66M3.32%$157.71M
Great point partners183.33K3.30%$17.45M
Sio capital management177.12K2.79%$16.86M
Deep track capital, lp1.93M2.67%$183.30M

Top Buyers

HolderShares% AssetsChange
Ra capital management1.55M1.29%1.55M
Bellevue group1.66M3.32%1.15M
T. rowe price investment management1.10M0.07%1.10M
Fmr10.15M0.04%1.09M
Rtw investments, lp3.14M2.55%1.08M

Top Sellers

HolderShares% AssetsChange
Commodore capital lp---1.75M
Avoro capital advisors---1.33M
Viking global investors lp1.50M0.41%-1.16M
Mercer global advisors inc /adv1.08K0.00%-801.39K
Bnp paribas arbitrage, snc459.53K0.01%-619.49K

New Positions

HolderShares% AssetsChangeValue
Ra capital management1.55M1.29%1.55M$147.95M
T. rowe price investment management1.10M0.07%1.10M$105.04M
Summit partners public asset management658.30K1.10%658.30K$62.65M
Macquarie management219.04K0.03%219.04K$20.85M
First turn management155.34K1.58%155.34K$14.78M

Sold Out

HolderChange
Mai capital management-1.00
National bank of canada /fi/-5.00
Ares financial consulting-7.00
Ameritas advisory services-11.00
Key capital management-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20262680.37%76,729,2952.89%1220.87%161-18.27%7862.50%
Jun 30, 202626340.64%74,518,41643.25%1351.52%19554.76%4746.88%
Mar 31, 202618226.39%52,177,550-1.28%1140.80%12525.00%3087.50%
Dec 31, 202562-43.12%11,958,114-73.75%270.23%45-28.57%4-82.61%
Sep 30, 202542-48.15%6,253,192-81.84%140.22%25-51.92%9-35.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest1.90M2.87%172.06K
Vanguard Morn Total Stk Mkt Idx Investor1.73M2.86%5.92K
Vanguard Total Stock Mkt Idx Inv1.73M2.86%5.92K
Fidelity Growth Compy Commingled Pl S1.70M2.81%54.10K
State Street® SPDR® S&P® Biotech ETF1.73M2.62%45.19K
American Funds SMALLCAP World A1.53M2.31%-
Capital Group New Economy Comp1.32M2.19%1.32M
American Funds New Economy A1.32M2.00%-
Fidelity Growth Company Fund1.29M1.95%-
iShares Russell 2000 ETF1.28M1.93%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 16, 2026Goncalves Joana Chief Medical OfficerSell$192.90K
Nov 16, 2026Goncalves Joana Chief Medical OfficerSell$30.74K
Nov 16, 2026Goncalves Joana Chief Medical OfficerSell$258.74K
Nov 16, 2026Goncalves Joana Chief Medical OfficerSell$150.72K
Nov 16, 2026Goncalves Joana Chief Medical OfficerSell$20.67K

Insider Transactions Trends


DateBuySell
2026 Q4-40
2026 Q3-50
2026 Q2-34
2026 Q1-17
2025 Q4-4

ORKA Ownership FAQ


Who Owns Oruka Therapeutics?

Oruka Therapeutics shareholders are primarily institutional investors at 122.04%, followed by 1.23% insiders and -23.27% retail investors. The average institutional ownership in Oruka Therapeutics's industry, Biotech Stocks , is 181.42%, which Oruka Therapeutics falls below.

Who owns the most shares of Oruka Therapeutics?

Oruka Therapeutics’s largest shareholders are Fmr (10.15M shares, 16.14%), Blackrock funding, inc. /de (5.21M shares, 8.29%), and Vr adviser (4.15M shares, 7.52%). Together, they hold 31.95% of Oruka Therapeutics’s total shares outstanding.

Does Blackrock own Oruka Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oruka Therapeutics.

Who is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested?

Remedium capital partners is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested, with 29.05% of its assets in 954.15K Oruka Therapeutics shares, valued at 79.47M$.

Who is the top mutual fund holder of Oruka Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Oruka Therapeutics shares, with 2.87% of its total shares outstanding invested in 1.9M Oruka Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools